Clarapath
Matthew Claster is an experienced executive in the healthcare and finance sectors, currently serving as Chief Business Officer at Clarapath since October 2020, where Matthew drives automation in pathology through medical robotics. Previously, Matthew held the position of Director at Northwell Ventures, focusing on venture capital investments in healthcare technology from January 2019 to April 2022. Prior experience includes a role as Director/Team Leader at Pfizer for business development evaluation, along with positions in investment banking at Citigroup Global Markets, Carl Marks Advisory Group, and CIT. Matthew holds an MBA in Finance from NYU Stern School of Business and a BA in Economics from Emory University.